Accu-Chek Solo and Abbott Acquiring Bigfoot Biomedical

0

0

0 Views· 09/19/23

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
0 Subscribers

In Drama

In this episode, hosts discuss a pair of topics making headlines in recent weeks: the US Food and Drug Administration’s 510(k) clearance for the Accu-Chek Solo micropump system and Abbott’s acquisition of Bigfoot Biomedical.

Show more

0 Comments

Up next

Autoplay

Home

Explore more

Help